Can you provide the upcoming earnings date for NOVABAY PHARMACEUTICALS INC?
NOVABAY PHARMACEUTICALS INC (NBY) will report earnings on 2026-05-13.
NOVABAY PHARMACEUTICALS INC (NBY) Forecast, Price Target & Analyst Ratings
NYSEARCA:NBY • US66987P4090
Current stock price
1.95 USD
+0.36 (+22.64%)
At close:
1.98 USD
+0.03 (+1.54%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NOVABAY PHARMACEUTICALS INC (NBY).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.20
- Revenue Estimate
- 3.636M
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $1.95 to mean target of N/A, Based on 5 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
NBY was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NBY.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed NBY. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-11-11 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2023-08-11 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2022-05-20 | Ascendiant Capital | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.20
- Revenue Estimate
- 3.636M
- Revenue Q2Q
- 20.00%
- EPS Q2Q
- 16.67%
- Number of Analysts
- 2
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
NBY is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.2 USD and the consensus revenue estimate is 3.64M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2025 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 14.4M 71.02% | 14.726M 2.26% | 9.781M -33.58% | 12.12M 23.91% | 16.004M 32.05% | |
| EBITDA YoY % growth | -7.2M -6.82% | -4.8M 33.33% | -4.934M -2.79% | -2.626M 46.78% | N/A | |
| EBIT YoY % growth | -7.68M -11.95% | -5.003M 34.86% | -4.974M 0.58% | -4.04M 18.78% | -2.586M 36.00% | |
| Operating Margin | -53.33% | -33.97% | -50.85% | -33.33% | -16.16% | |
| EPS YoY % growth | -1,300.25 -41.52% | -558.25 57.07% | N/A 99.74% | -0.87 39.01% | -0.38 55.81% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.20 16.67% | -0.11 47.62% | -0.12 42.86% | 0.03 115.00% |
| Revenue Q2Q % growth | 3.636M 20.00% | 3.317M | 3.796M 628.60% | 5.256M |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.232M -10.91% | -727.2K 61.54% | -838.3K 28.29% | 212.1K 111.63% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
NOVABAY PHARMACEUTICALS INC / NBY Forecast FAQ
What are the consensus estimates for NOVABAY PHARMACEUTICALS INC (NBY) next earnings?
The consensus EPS estimate for the next earnings of NOVABAY PHARMACEUTICALS INC (NBY) is -0.2 USD and the consensus revenue estimate is 3.64M USD.
Can you provide the analyst count for NOVABAY PHARMACEUTICALS INC stock?
The number of analysts covering NOVABAY PHARMACEUTICALS INC (NBY) is 5.